Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Morvan syndrome is a rare, life-threatening, acquired neurologic disease characterized by neuromyotonia, dysautonomia and encephalopathy with severe insomnia. Signs involving central (e.g. hallucinations, confusion, amnesia, myoclonus), autonomic (e.g. variations in blood pressure, hyperhidrosis) and peripheral (e.g. painful cramps, myokymia) hyperactivity, as well as systemic manifestations (such as weight loss, pruritus, fever), are reported. Thymoma is present in some cases.
Features include common findings: Anti-CASPR2.
Biomarker and diagnostic research for Morvan syndrome has been reported in the published literature.
Phenotype severity distribution: 1 common feature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Morvan syndrome.
145 publications have been identified in PubMed for Morvan syndrome. Research spans Review / Meta-Analysis (30%), Case Report / Case Series (26%), and Basic Science / Preclinical (14%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 44 | 30% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 11:53 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Morvan syndrome
37 |
26% |
Laboratory research | 20 | 14% |
Other research | 19 | 13% |
Clinical study results | 8 | 6% |
Disease patterns and progression | 7 | 5% |
Testing and diagnosis research | 6 | 4% |
New treatment approaches | 4 | 3% |
Altabakhi I (2026). [PMID: 30137808](https://pubmed.ncbi.nlm.nih.gov/30137808/). *Unknown Journal*. [Other]
Schuh A (2026). [PMID: 41236549](https://pubmed.ncbi.nlm.nih.gov/41236549/). *Orthopadie (Heidelb)*. [Review / Meta-Analysis]
Jabbari B (2026). [PMID: 30422576](https://pubmed.ncbi.nlm.nih.gov/30422576/). *Unknown Journal*. [Other]
Peng LY (2026). [PMID: 41645108](https://pubmed.ncbi.nlm.nih.gov/41645108/). *BMC pediatrics*. [Case Report / Case Series]
Katirji B (2026). [PMID: 42124386](https://pubmed.ncbi.nlm.nih.gov/42124386/). *Muscle Nerve*. [Other]
Shah KP (2026). [PMID: 34033319](https://pubmed.ncbi.nlm.nih.gov/34033319/). *Unknown Journal*. [Basic Science / Preclinical]
Cakar MM (2026). [PMID: 41348524](https://pubmed.ncbi.nlm.nih.gov/41348524/). *Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society*. [Case Report / Case Series]
Masood W (2026). [PMID: 29939664](https://pubmed.ncbi.nlm.nih.gov/29939664/). *Unknown Journal*. [Other]
Malik TF (2026). [PMID: 33760556](https://pubmed.ncbi.nlm.nih.gov/33760556/). *Unknown Journal*. [Other]
Aly R (2026). [PMID: 32809473](https://pubmed.ncbi.nlm.nih.gov/32809473/). *Unknown Journal*. [Other]
AI-curated news mentioning Morvan syndrome
Updated Aug 25, 2026
A new study investigates cardiovascular autonomic dysfunction in Morvan syndrome, focusing on heart rate variability and autonomic reflex tests. This research provides insights into the cardiovascular implications of this rare neurological disorder.
A case study highlights Morvan syndrome in a patient with progressing metastatic thymoma and myasthenia gravis, contributing to the understanding of this rare neurological condition. This research may inform future studies on the interplay between these diseases.